Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dermata Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-KS-110-Q10-Q
Operating expenses:          
Research and development    5.14.43.52.51.81.3
General and administrative    4.74.04.43.32.82.8
    Total operating expenses    9.88.47.95.84.64.1
    Loss from operations    -9.8-8.4-7.9-5.8-4.6-4.1
   
Other income and expenses:          
Interest income, net       -0.1-0.1-0.2
    Net loss    -9.8-8.4-7.9-5.7-4.6-4.1
   
Net loss per share of common stock, basic and diluted    ($9.85)($6.65)($2.51)($2.97)($2.42)($2.15)
   
Weighted-average basic and diluted common shares    2.62.93.32.71.91.9

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy